Literature DB >> 16672008

Pediatric Asthma Quality of Life Questionnaire (PAQLQ): validation among asthmatic children in Thailand.

Orapan Poachanukoon1, Nualanong Visitsunthorn, Watcharee Leurmarnkul, Pakit Vichyanond.   

Abstract

Quality of life (QoL) is an important consideration among asthma sufferers. The Pediatric Asthma Quality of Life Questionnaire (PAQLQ) is one of the most widely used instruments for measuring health-related QoL in children with asthma. The standardized version of PAQLQ contains 23 questions in three domains, i.e., activity limitation, symptoms and emotional function. The objective of this study was to validate the Thai-translated version of the PAQLQ. The study design consisted of a five-week single cohort study. Patients recorded symptoms, and peak expiratory flow rate (PEFR) each morning and evening during the first and fifth week of the study in asthma diary. At each clinic visit, a trained-interviewer administered the PAQLQ and performed spirometric measurements. Fifty-one children, ages between 7 and 17 yr participated in the study. Scores from the asthma diary were used to classify patients into stable vs. unstable groups. The construct validity of the questionnaire was confirmed in both cross-sectional and longitudinal studies by demonstrating correlations between various PAQLQ domains with clinical asthma parameters (asthma diary, beta-agonist use and PEFR). There was high internal consistency for scores of the three domains (Cronbach's alpha-coefficient = 0.83-0.95). For those with stable asthma, the reliability of PAQLQ was good for the rating scale (intra-class correlation coefficient--ICC = 0.84) and for total score (alpha = 0.97) indicating high reproducibility of the PAQLQ. The significant difference of changes QoL scores between stable and unstable groups was observed in all domains. We conclude that the Thai version of PAQLQ is valid and reliable for implementing in Thai children with asthma.

Entities:  

Mesh:

Year:  2006        PMID: 16672008     DOI: 10.1111/j.1399-3038.2005.00349.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  5 in total

Review 1.  Asthma outcomes: quality of life.

Authors:  Sandra R Wilson; Cynthia S Rand; Michael D Cabana; Michael B Foggs; Jill S Halterman; Lynn Olson; William M Vollmer; Rosalind J Wright; Virginia Taggart
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

2.  Tai-Chi-Chuan Exercise Improves Pulmonary Function and Decreases Exhaled Nitric Oxide Level in Both Asthmatic and Nonasthmatic Children and Improves Quality of Life in Children with Asthma.

Authors:  Hsin-Chia Lin; Hao-Pai Lin; Hsin-Hui Yu; Li-Chieh Wang; Jyh-Hong Lee; Yu-Tsan Lin; Yao-Hsu Yang; Pei-Yi Li; Wei-Zen Sun; Bor-Luen Chiang
Journal:  Evid Based Complement Alternat Med       Date:  2017-04-13       Impact factor: 2.629

3.  Relation of Asthma Control with Quality of Life among a Sample of Egyptian Asthmatic School Children.

Authors:  Hala G Elnady; Lobna S Sherif; Rania N Sabry; Dina Abu Zeid; Hanan Atta; Amal I Hassanain; Walaa A Fouad; Thanaa Rabah; Ayman A Gobarah
Journal:  Open Access Maced J Med Sci       Date:  2019-09-13

4.  Impact of Pediatric Alopecia Areata on Quality of Life of Patients and Their Family Members: A Nationwide Multicenter Questionnaire Study.

Authors:  Jee Woong Choi; Yul Hee Kim; Hyunbin Kwak; Jin Park; Won-Soo Lee; Hoon Kang; Jung Eun Kim; Tae-Young Yoon; Ki-Ho Kim; Yong Hyun Jang; Do Won Kim; Moon-Bum Kim; Bark-Lynn Lew; Woo-Young Sim; Jiehyun Jeon; Soo Hong Seo; Ohsang Kwon; Chang-Hun Huh; Dong-Youn Lee; Yang Won Lee; Byung Choel Park; Chong Hyun Won; Do Young Kim; Hyojin Kim; Beom Joon Kim; Young Lee; Sang Seok Kim; Gwang Seong Choi
Journal:  Ann Dermatol       Date:  2022-08       Impact factor: 0.722

5.  Effects of an Asthma Education Camp Program on Quality of Life and Asthma Control among Thai Children with Asthma: A Quasi-Experimental Study.

Authors:  Sirasuda Sommanus; Raweerat Sitcharungsi; Saranath Lawpoolsri
Journal:  Healthcare (Basel)       Date:  2022-08-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.